© 2021 MJH Life Sciences and Neurology Live. All rights reserved.
© 2021 MJH Life Sciences™ and Neurology Live. All rights reserved.
Professor of medicine; co-director, Stanford Amyloid Center; and co-director, Stanford Multidisciplinary Sarcoidosis Program, Stanford University Medical Center
April 30, 2021
Analysis of current and newer therapies for the treatment of hereditary ATTR amyloidosis.
April 23, 2021
Expert discussion on the recent topline results released for vutrisiran in the HELIOS-A trial.
Discussion on the role of TTR protein stabilizers and gene silencers for treating hereditary ATTR amyloidosis.
April 16, 2021
Clinicians elaborate on key trial data revealed through the APOLLO and NEURO-TTR studies in hereditary ATTR amyloidosis.